Ketazolam (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ketazolam" in English language version.

refsWebsite

Global rank English rank

11nih.gov

4^th place

7doi.org

2^nd place

6web.archive.org

1^st place

4semanticscholar.org

11^th place

8^th place

1in.gov.br

3,151^st place

5,932^nd place

1non-benzodiazepines.org.uk

low place

1intekom.com

low place

1justice.gc.ca

2,540^th place

1,620^th place

1fda.gov

447^th place

338^th place

1dea.gov

8,191^st place

5,785^th place

dea.gov

Drug Enforcement Administration (USA). "Drug Scheduling". United States Government. Archived from the original on 27 May 2018. Retrieved 26 August 2008.

doi.org

Vega D, Fernández D, Echeverría G (July 2001). "Ketazolam". Acta Crystallographica Section C. 57 (Pt 7): 848–850. doi:10.1107/S0108270101006175. PMID 11443263.
Fabre LF, Harris RT (1976). "Double-blind placebo-controlled efficacy study of ketazolam (U-28,774)". The Journal of International Medical Research. 4 (1): 50–54. doi:10.1177/030006057600400107. PMID 16791. S2CID 26311555.
Rickels K, Csanalosi I, Greisman P, Mirman MJ, Morris RJ, Weise CC, Weiss G (October 1980). "Ketazolam and diazepam in anxiety: a controlled study". Journal of Clinical Pharmacology. 20 (10): 581–589. doi:10.1002/j.1552-4604.1980.tb01673.x. PMID 6108335. S2CID 6597368.
Katz RT (June 1988). "Management of spasticity". American Journal of Physical Medicine & Rehabilitation. 67 (3): 108–116. doi:10.1097/00002060-198806000-00004. PMID 3288246. S2CID 45292155.
Higgitt A, Fonagy P, Lader M (1988). "The natural history of tolerance to the benzodiazepines". Psychological Medicine. Monograph Supplement. 13: 1–55. doi:10.1017/S0264180100000412. PMID 2908516. S2CID 38037200.
Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, et al. (November 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Annales Pharmaceutiques Françaises. 67 (6): 408–413. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
Joyce JR, Bal TS, Ardrey RE, Stevens HM, Moffat AC (June 1984). "The decomposition of benzodiazepines during analysis by capillary gas chromatography/mass spectrometry". Biomedical Mass Spectrometry. 11 (6): 284–289. doi:10.1002/bms.1200110607. PMID 6743768.

fda.gov

Food and Drug Administration (January 2006). "FDA Public Health Advisory - Consumers Filling U.S. Prescriptions Abroad May Get the Wrong Active Ingredient Because of Confusing Drug Names". FDA (USA). Archived from the original on 12 August 2006. Retrieved 26 August 2006.

in.gov.br

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

intekom.com

home.intekom.com

"SOLATRAN 15 (capsules) - SOLATRAN 30 (capsules)". South African Electronic Package Inserts. 12 November 1985. Archived from the original on 2 June 2019. Retrieved 26 August 2008.

justice.gc.ca

laws-lois.justice.gc.ca

"Controlled Drugs and Substances Act". laws-lois.justice.gc.ca. Archived from the original on 2013-12-15.

nih.gov

pubmed.ncbi.nlm.nih.gov

Vega D, Fernández D, Echeverría G (July 2001). "Ketazolam". Acta Crystallographica Section C. 57 (Pt 7): 848–850. doi:10.1107/S0108270101006175. PMID 11443263.
Anhalt HS, Young R, Roginsky M (November 1980). "Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing". The Journal of Clinical Psychiatry. 41 (11): 386–392. PMID 6108319.
Kim KK, Sirman A, Trainor FS, Lee BY (1980). "Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo". Clinical Therapeutics. 3 (1): 9–14. PMID 6105920.
Fabre LF, Harris RT (1976). "Double-blind placebo-controlled efficacy study of ketazolam (U-28,774)". The Journal of International Medical Research. 4 (1): 50–54. doi:10.1177/030006057600400107. PMID 16791. S2CID 26311555.
Rickels K, Csanalosi I, Greisman P, Mirman MJ, Morris RJ, Weise CC, Weiss G (October 1980). "Ketazolam and diazepam in anxiety: a controlled study". Journal of Clinical Pharmacology. 20 (10): 581–589. doi:10.1002/j.1552-4604.1980.tb01673.x. PMID 6108335. S2CID 6597368.
Basmajian JV, Shankardass K, Russell D (August 1986). "Ketazolam once daily for spasticity: double-blind cross-over study". Archives of Physical Medicine and Rehabilitation. 67 (8): 556–557. PMID 2874780.
Katz RT (June 1988). "Management of spasticity". American Journal of Physical Medicine & Rehabilitation. 67 (3): 108–116. doi:10.1097/00002060-198806000-00004. PMID 3288246. S2CID 45292155.
Basmajian JV, Shankardass K, Russell D, Yucel V (November 1984). "Ketazolam treatment for spasticity: double-blind study of a new drug". Archives of Physical Medicine and Rehabilitation. 65 (11): 698–701. PMID 6149738.
Higgitt A, Fonagy P, Lader M (1988). "The natural history of tolerance to the benzodiazepines". Psychological Medicine. Monograph Supplement. 13: 1–55. doi:10.1017/S0264180100000412. PMID 2908516. S2CID 38037200.
Authier N, Balayssac D, Sautereau M, Zangarelli A, Courty P, Somogyi AA, et al. (November 2009). "Benzodiazepine dependence: focus on withdrawal syndrome". Annales Pharmaceutiques Françaises. 67 (6): 408–413. doi:10.1016/j.pharma.2009.07.001. PMID 19900604.
Joyce JR, Bal TS, Ardrey RE, Stevens HM, Moffat AC (June 1984). "The decomposition of benzodiazepines during analysis by capillary gas chromatography/mass spectrometry". Biomedical Mass Spectrometry. 11 (6): 284–289. doi:10.1002/bms.1200110607. PMID 6743768.

non-benzodiazepines.org.uk

"Benzodiazepine Names". The Tranquilliser Recovery and Awareness Place. Archived from the original on 8 December 2008. Retrieved 26 August 2008.

semanticscholar.org

api.semanticscholar.org

Fabre LF, Harris RT (1976). "Double-blind placebo-controlled efficacy study of ketazolam (U-28,774)". The Journal of International Medical Research. 4 (1): 50–54. doi:10.1177/030006057600400107. PMID 16791. S2CID 26311555.
Rickels K, Csanalosi I, Greisman P, Mirman MJ, Morris RJ, Weise CC, Weiss G (October 1980). "Ketazolam and diazepam in anxiety: a controlled study". Journal of Clinical Pharmacology. 20 (10): 581–589. doi:10.1002/j.1552-4604.1980.tb01673.x. PMID 6108335. S2CID 6597368.
Katz RT (June 1988). "Management of spasticity". American Journal of Physical Medicine & Rehabilitation. 67 (3): 108–116. doi:10.1097/00002060-198806000-00004. PMID 3288246. S2CID 45292155.
Higgitt A, Fonagy P, Lader M (1988). "The natural history of tolerance to the benzodiazepines". Psychological Medicine. Monograph Supplement. 13: 1–55. doi:10.1017/S0264180100000412. PMID 2908516. S2CID 38037200.

web.archive.org

Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
"Benzodiazepine Names". The Tranquilliser Recovery and Awareness Place. Archived from the original on 8 December 2008. Retrieved 26 August 2008.
"SOLATRAN 15 (capsules) - SOLATRAN 30 (capsules)". South African Electronic Package Inserts. 12 November 1985. Archived from the original on 2 June 2019. Retrieved 26 August 2008.
"Controlled Drugs and Substances Act". laws-lois.justice.gc.ca. Archived from the original on 2013-12-15.
Food and Drug Administration (January 2006). "FDA Public Health Advisory - Consumers Filling U.S. Prescriptions Abroad May Get the Wrong Active Ingredient Because of Confusing Drug Names". FDA (USA). Archived from the original on 12 August 2006. Retrieved 26 August 2006.
Drug Enforcement Administration (USA). "Drug Scheduling". United States Government. Archived from the original on 27 May 2018. Retrieved 26 August 2008.